Drugs & medicalClass II

Philips Healthcare (Suzhou) Co., Ltd. recalls Incisive CT, model 728143 & 728144 running Software Version 5.0.0.

Multiple software issues which have the potential to lead to misdiagnosis due to image artifacts or incorrect image orientation labels, or the need for a CT rescan. These include: 1. Artifacts may occur on perfusion…

Read the official notice →
Date
2024-01-17
Country
United States
Brand
Philips Healthcare
Product
Incisive CT, model 728143 & 728144 running Software Version 5.0.0.
Classification
Class II
Units
Worldwide - US Nationwide distribution including in the states of AL, AR, AZ,…
Category
Drugs & medical
Source
FDA · Device

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Philips Healthcare recalls

  1. 2026-09-02
  2. US
    Drugs & medicalClass II

    Philips Healthcare (Suzhou) Co., Ltd. recalls Philips Incisive CT with software V4.5&V5.0, Product Code 728143 and Product Code 728144.

    Potential of failing to trigger clinical scan during Bolus Tracking.

    FDA · DevicePhilips Healthcare (Suzhou) Co., Ltd.U.S. Nationwide and U.S. Territories distribution.Official notice →
  3. 2026-01-14
  4. US
    Drugs & medicalClass II

    Philips Healthcare (Suzhou) Co., Ltd. recalls Philips Incisive CT

    Potential for incomplete scan due to unstable connection inside of floating sensor.

    FDA · DevicePhilips Healthcare (Suzhou) Co., Ltd.U.S. and U.S. territoriesOfficial notice →
  5. 2023-10-11
  6. US
    Drugs & medicalClass II

    Philips Healthcare recalls Incisive CT, software version 5.0

    Philips has identified three software issues with compliance concerns to Subchapter J: Issue 1: Coronary Computed Tomography Angiography (CTA) scan may not be triggered at the optimal time. Issue 2: Use of aborted…

    FDA · DevicePhilips HealthcareUS Nationwide DistributionOfficial notice →
  7. 2022-04-13
  8. US
    Drugs & medicalClass II

    Philips Healthcare recalls Philips StentBoost Live R2.0 application, when used with the Philips Azurion with software release R2.x

    Due to an incorrect configuration setting in the EPX database of StentBoost Live, acquisition does not stop automatically as it should. When the user selects the StentBoost Live protocol on the Philips Azurion system,…

    FDA · DevicePhilips HealthcareUS Nationwide distribution.Official notice →
  9. 2022-03-30
  10. US
    Drugs & medicalClass II

    Philips Healthcare recalls Azurion systems with software release R2.0.x

    In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a…

    FDA · DevicePhilips HealthcareUS Nationwide DistributionOfficial notice →
  11. 2021-12-01
  12. US
    Drugs & medicalClass II

    Philips Healthcare recalls CombiDiagnost R90 is multi-functional general R/F systems.

    The Aleva monitor requires certain labels to be applied, some of which are required by FDA Electronic Product Radiation Control performance standards. This includes the Radiation Warning Label [21CFR 1020.30 (j)] and…

    FDA · DevicePhilips HealthcareUS Nationwide DistributionOfficial notice →
All 8 Philips Healthcare recalls →

Other drugs & medical recalls in the United States

  1. 2024-01-17
  2. US
    Drugs & medicalClass II

    Olympus Corporation of the Americas recalls OLYMPUS ENDOEYE FLEX DEFLECTABLE VIDEOSCOPE (5.4 mm diameter) Model: LTF-S190-5 Used with a video system center, light…

    Instructions for Use-User Deviations related to the reprocessing of the videoscope detailed in the Reprocessing Manual Instructions. The steps are required for the proper reprocessing of these videoscopes

    FDA · DeviceOlympus Corporation of the AmericasNationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Bard Peripheral Vascular Inc recalls Bard Mission Disposable Core Biopsy Instrument Kit (REF/Name): 1410MSK/ Mission Kit 14G x 10CM; 1416MSK/ Mission Kit 14G x 16CM;…

    The internal diameter of the coaxial cannula may be smaller or larger than the external diameter of the biopsy needle, and the length of the cannula may exceed the stated length on the label. As a result, the biopsy…

    FDA · DeviceBard Peripheral Vascular IncWorldwide - US Nationwide distribution including in the states of PR, IL, MA,…Official notice →
  4. US
    Drugs & medicalClass II

    Becton, Dickinson and Company, BD Biosciences recalls CD11b APC: ASR, REF: 340936, and CE, REF: 333143

    In vitro diagnostics product that impacts the quality of cell staining can cause low or dim fluorescence signal, which can lead to potential false negative results and misdiagnosis of hematological malignancy, delayed…

    FDA · DeviceBecton, Dickinson and Company, BD BiosciencesWorldwide - US Nationwide distribution including in the states of IL, MN, FL,…Official notice →
  5. US
    Drugs & medicalClass II

    Dr. Reddy's Laboratories, Inc. recalls Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC…

    Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.

    FDA · DrugDr. Reddy's Laboratories, Inc.USA NationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma…

    Presence of Foreign Tablets/Capsules

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the United StatesOfficial notice →
  7. US
    Drugs & medicalClass II

    Lupin Pharmaceuticals Inc. recalls Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for:…

    CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

    FDA · DrugLupin Pharmaceuticals Inc.Product was distributed nationwide.Official notice →
See all drugs & medical recalls →